Antimicrobial efficacy of a nitric oxide-releasing ampicillin conjugate catheter lock solution on clinically-isolated antibiotic-resistant bacteria.
Journal
Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571
Informations de publication
Date de publication:
26 Sep 2023
26 Sep 2023
Historique:
pmc-release:
26
09
2024
medline:
4
10
2023
pubmed:
18
8
2023
entrez:
18
8
2023
Statut:
epublish
Résumé
Antibiotic lock therapy (ALT) is standard clinical practice for treating bacteremia linked with catheter-related bloodstream infections (CRBSIs). However, this strategy frequently fails against multi-drug-resistant bacteria in clinical settings. In this study, a novel approach to utilize a nitric oxide (NO) donor
Identifiants
pubmed: 37594048
doi: 10.1039/d3bm00775h
pmc: PMC10529818
mid: NIHMS1927029
doi:
Substances chimiques
Anti-Bacterial Agents
0
Nitric Oxide
31C4KY9ESH
Ampicillin
7C782967RD
Anti-Infective Agents
0
Nitric Oxide Donors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6561-6572Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL134899
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151473
Pays : United States
Références
J Bacteriol. 2009 Dec;191(23):7333-42
pubmed: 19801410
ACS Appl Mater Interfaces. 2023 Mar 29;15(12):15185-15194
pubmed: 36926823
Int J Med Microbiol. 2006 Apr;296(2-3):149-61
pubmed: 16503194
Infect Drug Resist. 2014 Dec 12;7:343-63
pubmed: 25548523
Pathogens. 2021 Feb 04;10(2):
pubmed: 33557078
J Innate Immun. 2019;11(3):205-215
pubmed: 30557874
J Control Release. 2022 Sep;349:227-240
pubmed: 35777483
Mt Sinai J Med. 2010 Sep-Oct;77(5):549-58
pubmed: 20960556
ACS Appl Bio Mater. 2022 Apr 18;5(4):1519-1527
pubmed: 35343228
J Pharmacol Exp Ther. 1993 Dec;267(3):1529-37
pubmed: 7903392
Nitric Oxide. 2019 Nov 1;92:18-25
pubmed: 31398487
Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1924-1932
pubmed: 30309840
ACS Appl Mater Interfaces. 2021 Jun 9;13(22):25813-25824
pubmed: 34029456
Clin Infect Dis. 2001 May 1;32(9):1249-72
pubmed: 11303260
Clin Infect Dis. 1992 Aug;15(2):197-208
pubmed: 1520756
Clin Infect Dis. 2002 May 1;34(9):1232-42
pubmed: 11941550
ACS Appl Mater Interfaces. 2021 Dec 8;13(48):56931-56943
pubmed: 34818503
Nat Rev Microbiol. 2004 Oct;2(10):820-32
pubmed: 15378046
Free Radic Biol Med. 1998 Sep;25(4-5):434-56
pubmed: 9741580
J Clin Diagn Res. 2013 Feb;7(2):243-6
pubmed: 23543704
Nurs Res Pract. 2015;2015:985686
pubmed: 26075094
Chem Soc Rev. 2012 May 21;41(10):3742-52
pubmed: 22362384
Virulence. 2012 May 1;3(3):271-9
pubmed: 22546899
ACS Appl Mater Interfaces. 2022 May 18;14(19):21916-21930
pubmed: 35507415
J Med Chem. 2020 Sep 10;63(17):9127-9135
pubmed: 32787095
J Biomed Mater Res A. 2023 Apr;111(4):451-464
pubmed: 36594584
ACS Biomater Sci Eng. 2023 Mar 13;9(3):1694-1705
pubmed: 36542753
J Phys Chem A. 2016 Jun 23;120(24):4191-200
pubmed: 27249061
Antioxid Redox Signal. 2012 Oct 1;17(7):969-80
pubmed: 22468855
Clin Infect Dis. 2011 May;52(9):e162-93
pubmed: 21460264
Int J Crit Illn Inj Sci. 2014 Apr;4(2):162-7
pubmed: 25024944
Mol Ther. 2017 Sep 6;25(9):2104-2116
pubmed: 28750737
Antimicrob Agents Chemother. 2007 Jan;51(1):54-63
pubmed: 17088489
J Clin Invest. 1997 Jun 15;99(12):2818-25
pubmed: 9185502
Biotechnol Bioeng. 2008 May 1;100(1):1-18
pubmed: 18366134
Antimicrob Resist Infect Control. 2019 May 16;8:76
pubmed: 31131107
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29263060